Determination of L-365,260, a new cholecystokinin receptor (CCK-B) antagonist, in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry-Reference-Cited by-同舟云学术

Determination of L-365,260, a new cholecystokinin receptor (CCK-B) antagonist, in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry

Published:1992-02 Issue:2 Volume:21 Page:63-68
ISSN:1052-9306
Container-title:Biological Mass Spectrometry
language:en
Short-container-title:Biol. Mass Spectrom.

Author:

Gilbert J. D.,Hand E. L.,Yuan A. S.,Olah T. V.,Covey T. R.

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Spectroscopy

Reference20 articles.

1. CHOLECYSTOKININ: A HORMONE AND A NEUROTRANSMITTER

2. Brain CCK receptors are structurally distinct from pancreas CCK receptors

3. Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

4. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Forty‐Year Evolution of High‐Throughput Mass Spectrometry;High‐Throughput Mass Spectrometry in Drug Discovery;2023-06-30

2. ESI, APCI, and MALDI a Comparison of the Central Analytical Figures of Merit: Sensitivity, Reproducibility, and Speed;Electrospray and MALDI Mass Spectrometry;2012-11-27

3. Drug Metabolism and Reactive Metabolites;Hit and Lead Profiling;2009-08-19

4. Ultra-low flow nanospray for the normalization of conventional liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery;Rapid Communications in Mass Spectrometry;2006

5. Advances in High Throughput Quantitative Drug Discovery Bioanalysis;Integrated Strategies for Drug Discovery Using Mass Spectrometry;2005-01-27